These evidences encourage the development of complementary metabolic and molecular research to elucidate the mechanism of action of NAM to propose it as a possible therapeutic molecule to prevent or treat dyslipidemia and oxidative stress generated by high-calorie diets. Here, STAC3 is linked to metabolic syndrome.